ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Fibrosis"

  • 2020 American Transplant Congress

    Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis

    S. Sataphaty1, P. Banerjee2, J. Pierre3, R. Heda3, S. Dutta3, D. D. Higgins4, V. Mas5, S. Khan6, V. Mupparaju3, S. R. Nair7, J. D. Eason8, D. Kleiner9, D. Maluf10

    1Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, 2School of Public Health, University of Memphis, Memphis, TN, 3University of Tennessee Health Science Center, Memphis, TN, 4University of Memphis, Memphis, TN, 5James D Eason Transplant Institute, Memphis, TN, 6Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, 7Department of Surgery, James D Eason Transplant Institute, Memphis, TN, 8Department of Surgery, James D Eason Transplant Institute, NYC, TN, 9Laboratory of Pathology/National Cancer Institute, Bethesda, WA, 10Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN

    *Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
  • 2020 American Transplant Congress

    Graphene Quantum Dots Prevent Glomerular and Interstitial Injury in Murine Adriamycin Nephropathy Through Macrophage Depletion

    Y. Kim1, K. Kim1, J. Lee1, J. Moon1, J. Kim1, J. Lee2, Y. Kim1, S. Yang1

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, 2Internal Medicine, Nephrology Clinic, National Cancer Center, Seoul, Korea, Republic of

    *Purpose: Macrophage infilatration is a key feature of the pathogenicity associated with glomerular and tubulo-interstitial injury in kidney disease. Graphene quantum dots (GQDs) are considered…
  • 2020 American Transplant Congress

    Fibrosing Cholestatic Hepatatitis in Post Renal Transplant and Successful Treatment with Newer DAA Therapy

    V. Siddini

    Nephrology, Manipal Hospital, Bangalore, India

    *Purpose: Fibrosing cholestatic hepatitis is often fatal post renal transplantation. we report a case of successful treatment of FCH and complete recovery*Methods: A 53 year…
  • 2020 American Transplant Congress

    Molecular Phenotypes of Liver Transplant Injury: The INTERLIVER Study

    K. S. Madill-Thomsen1, P. F. Halloran1, &. the INTERLIVER Study Group2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2., ., AB, Canada

    *Purpose: Liver parenchymal injury phenotypes are difficult to evaluate by histology but could be amenable to molecular assessment. Having developed a Molecular Microscope® Diagnostic System…
  • 2020 American Transplant Congress

    Persistent Fibrinolysis Shutdown in Liver Transplant Recipients is Associated with Early Allograph Dysfunction

    H. B. Moore1, T. Nydam1, J. Pomposelli1, C. Walker1, A. Schulick1, R. Choudhury1, H. Yaffe1, M. Adams2, M. Cohen3, E. Pomfret1

    1University of Colorado, Aurora, CO, 2Childrens Hospital, Aurora, CO, 3Denver Health Medical Center, Denver, CO

    *Purpose: Early allograph dysfunction (EAD) in liver transplantation has been attributed to microvascular thrombosis. Treating grafts at risk of EAD with tissue plasminogen activator (tPA)…
  • 2020 American Transplant Congress

    Automatic Quantification of Interstitial Fibrosis in Renal Allograft

    J. Hogan1, J. Vizcarra2, M. A. Tageldin2, L. A. Cooper3, D. A. Gutman2, A. B. Farris4

    1Transplant Research Center, Department of Surgery, Emory University, Atlanta, GA, 2Computer Science Department, Emory University, Atlanta, GA, 3Pathology Department, Northwestern University, Evanston, IL, 4Pathology Department, Emory University, Atlanta, GA

    *Purpose: Renal allografts are typically assessed by pathologists using the Banff classification with known interobserver variability. We previously demonstrated the utility of image analysis in…
  • 2020 American Transplant Congress

    Gross Morphological Score for Deceased Donor Kidneys Can Predict Delayed Graft Function in Kidney Transplant Recipients

    M. Mandurah, M. A. Levine, A. Sener, P. Luke

    Department of Kidney Transplantation, London Health Sciences Center, London, ON, Canada

    *Purpose: Both microscopy and kidney donor profile index (KDPI) scoring systems have been used to predict kidney transplant outcomes. Utilizing gross renal morphology, we designed…
  • 2020 American Transplant Congress

    Bortezomib Exhibits Therapeutic Implication in Renal Interstitial Fibrosis after Kidney Transplantation by Inhibiting Akt-mTOR-P70S6K-Smurf2 Pathway and Stabilizing IκBα Protein

    C. Suo, Z. Gui, Z. Wang, J. Zhou, M. Zheng, H. Chen, S. Fei, L. Sun, X. Zhang, M. Gu, R. Tan

    Jiangsu Province Hospital, Nanjing, China

    *Purpose: Allograft interstitial fibrosis and fibrogenesis significantly exacerbate the progression of chronic allograft disease (CAD) and are essential therapeutic targets. Epithelial‐mesenchymal transition (EMT) is recognized…
  • 2020 American Transplant Congress

    Autophagy Attenuates Renal Allograft Interstitial Fibrosis by Regulating the EndMT Induced by TNF-α

    Z. Gui, C. Suo, Z. Wang, S. Fei, Z. Han, J. Tao, H. Chen, L. Sun, X. Ju, R. Tan, M. Gu

    Jiangsu Province Hospital, Nanjing, China

    *Purpose: Kidney interstitial fibrosis is a significant cause of allograft failure in kidney transplantation. Autophagy is a self-digestive process that eliminates impaired or aged proteins…
  • 2020 American Transplant Congress

    Divergent Molecular Pathways Underlie the Evolution of Allograft Fibrosis in Two Mouse Models of Chronic Lung Allograft Dysfunction

    T. Watanabe, J. Allen, K. Boonstra, Z. Guan, K. Bei, S. Keshavjee, J. Yeung, T. Martinu, S. Juvet

    Latner Thoracic Surgery Research Laboratories, Toronto Lung Transplant Program / University Health Network, Toronto, ON, Canada

    *Purpose: Chronic lung allograft dysfunction (CLAD) after lung transplantation (LTx) is potentiated by activation of the innate immune system and occurs in two patterns: diffuse…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences